Jade Biosciences (JBIO) Financials: Revenue & Earnings

JBIO price $14.46 -0.28 -1.90%

Ticker
JBIO
Price
$14.46
Change
-0.28 -1.90%
Market cap ?
$919.62M
Beta ?
1.45
Sector
Healthcare
Industry
Biotechnology

Fair value

JBIO fair value Not meaningful. Price $14.46.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare JBIO

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-12—-0.73——
2026-08-10-0.76-0.64——
2026-05-07-0.57-0.52——
2026-03-06-0.45-0.45——
2025-11-14-0.48-0.57——
2025-08-14-0.86-0.43——
2025-04-25-12.10-6.03——
2025-03-14-6.65-6.57——
2024-11-12-19.60-16.36——
2024-08-12-30.10-28.78——
2024-05-13-29.05-26.76——
2024-03-25-25.90-23.76——
2023-11-13-24.85-24.24——
2023-08-14-26.60-24.36——

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency Irregular.

Safety score 43/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. Dividend history is short. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
2025-04-29$2.402025-04-25—Irregular

Insider trades

DateInsiderActionSharesPriceValue
2026-06-25Eisner MarkBuy47.67K$21.811.04M
2026-06-25Eisner MarkOther0——
2026-06-09CAIN CHRISTOPHER W.Buy34.84K$15.22530.31K
2026-06-09DOBMEIER ERICBuy34.84K$15.22530.31K
2026-06-09Klein Lawrence OttoBuy34.84K$15.22530.31K
2026-06-09Lavelle ErinBuy34.84K$15.22530.31K
2026-06-09Fairmount Funds Management LLCBuy34.84K$15.22530.31K
2026-02-12Dahms Bradford D.Buy226.88K$14.813.36M
2026-02-12Dahms Bradford D.Buy37.81K——
2026-02-12Balta ElizabethBuy168.75K$14.812.50M
2026-02-12Balta ElizabethBuy28.12K——
2026-02-12Frohlich TomBuy472.50K$14.817.00M
2026-02-12Frohlich TomBuy78.75K——
2026-02-12King Andrew JamesBuy41.25K——
2026-02-12King Andrew JamesBuy247.50K$14.813.67M
2025-10-06Fairmount Funds Management LLCBuy1.33M$9.1412.18M
2025-10-06Fairmount Funds Management LLCBuy855.05K$0.0086
2025-07-14Dahms Bradford D.Buy526.00K$9.004.73M
2025-07-14Dahms Bradford D.Other0——
2025-05-16Frohlich TomBuy6.00K$7.4044.40K
2025-04-29Fairmount Funds Management LLCBuy23.02K$10.14233.39K
2025-04-29Lavelle ErinBuy23.02K$10.14233.39K
2025-04-29Klein Lawrence OttoBuy23.02K$10.14233.39K
2025-04-29CAIN CHRISTOPHER W.Buy23.02K$10.14233.39K
2025-04-29DOBMEIER ERICBuy23.02K$10.14233.39K
2025-04-28Fairmount Funds Management LLCOther0——
2025-04-28Fairmount Funds Management LLCOther0——
2025-04-28Fairmount Funds Management LLCOther4.94M$0.00494
2025-04-28Fairmount Funds Management LLCOther12.62M——
2025-04-28Lavelle ErinOther88.38K$6.03532.93K
2025-04-28Lavelle ErinOther46.56K$1.5371.23K
2025-04-28Klein Lawrence OttoOther0——
2025-04-28Klein Lawrence OttoOther48.72K$6.03293.78K
2025-04-28CAIN CHRISTOPHER W.Other0——
2025-04-28DOBMEIER ERICOther93.11K$2.32216.02K
2025-04-28DOBMEIER ERICOther176.77K$6.031.07M
2025-04-28Balta ElizabethOther139.67K$2.32324.03K
2025-04-28Balta ElizabethOther346.11K$6.032.09M
2025-04-28Kocinsky HetalOther186.22K$1.53284.92K
2025-04-28Kocinsky HetalOther353.53K$6.032.13M
2025-04-28King Andrew JamesOther0——
2025-04-28King Andrew JamesOther185.40K$2.32430.12K
2025-04-28King Andrew JamesOther552.71K$6.033.33M
2025-04-28King Andrew JamesOther27.59K$0.5013.79K
2025-04-28Quick JonathanOther321.02K$6.031.94M
2025-04-28Quick JonathanOther83.80K$1.53128.22K
2025-04-28Frohlich TomOther779.93K$6.034.70M
2025-04-28Frohlich TomOther931.13K$1.531.42M
2025-04-28RA CAPITAL MANAGEMENT, L.P.Buy1.06M——

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 158, holders +35 vs prior quarter. Ownership 126.38%.

HolderSharesChangeChange %Value
FMR LLC9.13M2.04M+28.81%202.80M
JUPITER TOPCO LLC6.27M6.27MNew139.37M
FAIRMOUNT FUNDS MANAGEMENT LLC4.55M00.00%101.18M
RA CAPITAL MANAGEMENT, L.P.3.67M00.00%81.57M
VENROCK ADVISER, LLC3.22M00.00%71.56M
BELLEVUE GROUP AG3.06M-443.51K-12.67%67.95M
PARADIGM BIOCAPITAL ADVISORS LP2.86M2.86MNew63.49M
BLACKROCK, INC.2.80M487.50K+21.07%62.25M
FRANKLIN TEMPLETON INC2.79M2.79MNew62.04M
STATE STREET CORP2.34M1.68M+256.16%51.89M
VANGUARD CAPITAL MANAGEMENT LLC2.24M448.12K+24.94%49.88M
ADAGE CAPITAL PARTNERS GP, L.L.C.1.91M1.91MNew42.46M
POLAR CAPITAL HOLDINGS PLC1.85M1.85MNew41.04M
AVIDITY PARTNERS MANAGEMENT LP1.70M300.00K+21.42%37.79M
REMEDIUM CAPITAL PARTNERS, LLC1.58M00.00%35.06M
SOLEUS CAPITAL MANAGEMENT, L.P.1.55M753.95K+94.63%34.46M
JPMORGAN CHASE & CO1.48M1.46M+9198.87%32.61M
BAKER BROS. ADVISORS LP1.23M-410.71K-25.03%27.34M
LOGOS GLOBAL MANAGEMENT LP1.12M725.00K+181.25%25.00M
VERSANT VENTURE MANAGEMENT, LLC991.78K-534.04K-35.00%22.04M
ACORN CAPITAL ADVISORS, LLC986.76K200.00K+25.42%21.93M
GEODE CAPITAL MANAGEMENT, LLC985.18K162.66K+19.78%21.90M
CITADEL ADVISORS LLC929.41K792.18K+577.30%20.65M
FORESITE CAPITAL MANAGEMENT VI LLC886.67K566.67K+177.08%19.70M
BALYASNY ASSET MANAGEMENT L.P.878.73K476.24K+118.32%19.53M

Earnings and financials

Jade Biosciences, Inc. (JBIO) trades at $14.46, with a market cap of $919.62M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Jade Biosciences (JBIO) Financials: Revenue & Earnings

JBIO$14.46-0.28 -1.90%

$919.62M

Market Cap

—

P/E

—

Forward P/E

—

Score

Price History